Establishment Labs Holdings PE Ratio 2017-2023 | ESTA
Current and historical p/e ratio for Establishment Labs Holdings (ESTA) from 2017 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Establishment Labs Holdings PE ratio as of March 27, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Establishment Labs Holdings PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-03-27 | 50.76 | 0.00 | |
2023-12-31 | 25.89 | $-3.04 | 0.00 |
2023-09-30 | 49.07 | $-2.80 | 0.00 |
2023-06-30 | 68.61 | $-2.44 | 0.00 |
2023-03-31 | 67.74 | $-3.31 | 0.00 |
2022-12-31 | 65.65 | $-3.42 | 0.00 |
2022-09-30 | 54.61 | $-3.48 | 0.00 |
2022-06-30 | 54.38 | $-2.94 | 0.00 |
2021-12-31 | 67.59 | $-1.71 | 0.00 |
2021-09-30 | 71.58 | $-1.35 | 0.00 |
2021-06-30 | 87.34 | $-0.98 | 0.00 |
2021-03-31 | 62.53 | $-0.94 | 0.00 |
2020-12-31 | 37.64 | $-1.10 | 0.00 |
2022-03-31 | 67.39 | $-1.66 | 0.00 |
2020-09-30 | 18.53 | $-1.69 | 0.00 |
2020-06-30 | 18.68 | $-2.13 | 0.00 |
2020-03-31 | 14.45 | $-2.12 | 0.00 |
2019-12-31 | 27.66 | $-1.86 | 0.00 |
2019-09-30 | 18.91 | $-2.11 | 0.00 |
2019-06-30 | 21.99 | $-1.43 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.381B | $0.165B |
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $120.995B | 15.70 |
Cencora (COR) | United States | $48.801B | 19.48 |
ICON (ICLR) | Ireland | $27.182B | 26.81 |
DiDi Global (DIDIY) | China | $18.509B | 0.00 |
Avantor (AVTR) | United States | $17.350B | 23.91 |
CochLear (CHEOY) | $14.477B | 0.00 | |
Viatris (VTRS) | United States | $14.192B | 4.05 |
Charles River Laboratories (CRL) | United States | $13.819B | 25.29 |
Revvity (RVTY) | United States | $13.021B | 22.67 |
Medpace Holdings (MEDP) | United States | $12.404B | 45.41 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $12.071B | 0.00 |
Natera (NTRA) | United States | $10.924B | 0.00 |
HealthEquity (HQY) | United States | $6.840B | 51.10 |
Amplifon S.p.A (AMFPF) | Italy | $6.762B | 34.33 |
Bausch + Lomb (BLCO) | Canada | $6.041B | 23.26 |
Doximity (DOCS) | United States | $5.035B | 37.49 |
Organon (OGN) | United States | $4.717B | 4.57 |
Surgery Partners (SGRY) | United States | $3.791B | 35.22 |
Progyny (PGNY) | United States | $3.666B | 61.27 |
Sotera Health (SHC) | United States | $3.357B | 16.49 |
Life Times (LTH) | United States | $3.031B | 33.50 |
GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
Premier (PINC) | United States | $2.612B | 9.56 |
Teladoc Health (TDOC) | United States | $2.551B | 0.00 |
Agilon Health (AGL) | United States | $2.347B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.329B | 7.53 |
BrightSpring Health Services (BTSG) | United States | $1.739B | 0.00 |
NovoCure (NVCR) | Jersey | $1.568B | 0.00 |
Agiliti (AGTI) | United States | $1.376B | 22.49 |
Alignment Healthcare (ALHC) | United States | $0.905B | 0.00 |
Pediatrix Medical (MD) | United States | $0.840B | 8.69 |
Embecta (EMBC) | United States | $0.743B | 4.90 |
InnovAge Holding (INNV) | United States | $0.590B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.588B | 0.00 |
Enhabit (EHAB) | United States | $0.580B | 52.54 |
Beauty Health (SKIN) | United States | $0.559B | 0.00 |
CareDx (CDNA) | United States | $0.545B | 0.00 |
MultiPlan (MPLN) | United States | $0.544B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.466B | 12.21 |
DocGo (DCGO) | United States | $0.423B | 67.67 |
LifeMD (LFMD) | United States | $0.411B | 0.00 |
ModivCare (MODV) | United States | $0.354B | 4.69 |
Sera Prognostics (SERA) | United States | $0.296B | 0.00 |
Sharecare (SHCR) | United States | $0.296B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.287B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.246B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.237B | 0.00 |
Biodesix (BDSX) | United States | $0.140B | 0.00 |
Oncology Institute (TOI) | United States | $0.136B | 0.00 |
So-Young (SY) | China | $0.108B | 36.00 |
Pono Capital Two (PTWO) | United States | $0.070B | 0.00 |
Nutex Health (NUTX) | United States | $0.068B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.052B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.038B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
OncoCyte (OCX) | United States | $0.025B | 0.00 |
DermTech (DMTK) | United States | $0.025B | 0.00 |
BIMI Medical (BIMI) | United States | $0.021B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.012B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.010B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |